Apellis Pharmaceuticals, Inc. (APLS)
NASDAQ: APLS · Real-Time Price · USD
33.21
+0.07 (0.21%)
Dec 20, 2024, 4:00 PM EST - Market closed
Apellis Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -250.1 | -528.63 | -652.17 | -746.35 | -344.87 | -304.71 | Upgrade
|
| Depreciation & Amortization | 1.83 | 1.78 | 1.55 | 1.49 | 0.86 | 0.6 | Upgrade
|
| Other Amortization | 1.05 | 0.3 | 0.46 | 0.96 | 15.54 | 2.34 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.03 | 0.12 | - | - | - | - | Upgrade
|
| Stock-Based Compensation | 114.03 | 105.95 | 91.09 | 70.67 | 45.38 | 21.14 | Upgrade
|
| Other Operating Activities | 17.31 | 25.92 | 61.03 | 203.63 | 103.03 | 16.34 | Upgrade
|
| Change in Accounts Receivable | -109.74 | -198.72 | 2.38 | -10.1 | - | - | Upgrade
|
| Change in Inventory | -68.59 | -60.65 | -69.4 | -16.32 | - | - | Upgrade
|
| Change in Accounts Payable | 19.22 | 0.17 | 18.69 | 10.49 | -0.05 | -1.64 | Upgrade
|
| Change in Other Net Operating Assets | 68.03 | 59.02 | 32.64 | -77.59 | 19.64 | 54.79 | Upgrade
|
| Operating Cash Flow | -205.1 | -594.74 | -513.75 | -563.13 | -160.49 | -211.14 | Upgrade
|
| Capital Expenditures | -0.48 | -0.77 | -1.52 | -1.1 | -5.42 | -1.69 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.1 | 0.1 | - | - | - | - | Upgrade
|
| Investment in Securities | - | - | 61.42 | 248.72 | -311.57 | - | Upgrade
|
| Investing Cash Flow | -0.38 | -0.67 | 59.89 | 247.62 | -316.99 | -1.69 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | 322.87 | 212.91 | Upgrade
|
| Long-Term Debt Repaid | - | - | - | - | - | -28.7 | Upgrade
|
| Net Debt Issued (Repaid) | 365.45 | - | - | - | 322.87 | 184.21 | Upgrade
|
| Issuance of Common Stock | 44.28 | 461.04 | 405.84 | 398.02 | 392.42 | 112.71 | Upgrade
|
| Repurchase of Common Stock | -0.04 | -11.04 | -5.68 | -1.79 | - | - | Upgrade
|
| Other Financing Activities | -260.36 | -55.5 | -34.5 | -4 | -23.11 | 91.62 | Upgrade
|
| Financing Cash Flow | 149.33 | 394.5 | 365.66 | 392.24 | 692.18 | 388.54 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.89 | 0.14 | -0.49 | -2.02 | 0.36 | 0 | Upgrade
|
| Net Cash Flow | -55.26 | -200.78 | -88.68 | 74.71 | 215.06 | 175.72 | Upgrade
|
| Free Cash Flow | -205.58 | -595.51 | -515.27 | -564.23 | -165.91 | -212.83 | Upgrade
|
| Free Cash Flow Margin | -28.74% | -150.16% | -683.18% | -847.66% | -66.19% | - | Upgrade
|
| Free Cash Flow Per Share | -1.67 | -5.02 | -4.86 | -6.68 | -2.21 | -3.42 | Upgrade
|
| Cash Interest Paid | 19.45 | 3.29 | 5 | 10.27 | 12.93 | 0.99 | Upgrade
|
| Cash Income Tax Paid | - | -1.76 | 4.92 | 0.05 | 1.65 | - | Upgrade
|
| Levered Free Cash Flow | -140.21 | -404.84 | -304.6 | -351.61 | -52.88 | -108.08 | Upgrade
|
| Unlevered Free Cash Flow | -118.6 | -386.65 | -284.66 | -344.3 | -49.7 | -107.11 | Upgrade
|
| Change in Net Working Capital | 94.4 | 170.41 | 4.14 | 80.19 | -43.06 | -52.85 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.